2022 Turkey Molecular Diagnostics Market Shares-Competitive Analysis of Leading and Emerging Market Players
This new report provides molecular diagnostics market shares.
The report analyses current and emerging suppliers of molecular diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
The report analyses current and emerging suppliers of molecular diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
iasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics/Carlyle Group
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
iasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics/Carlyle Group
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
More Publications
2021-2026 Turkey Virology, Bacteriology, Parasitology and Mycology Testing Database: Supplier Shares, Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Tests
US$ 1,750.00
January 2022
-
2021 Turkey Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Sales and Shares, Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 2,750.00
February 2021
1120 pages
